Literature DB >> 2137772

Murine splenocytes express a naloxone-insensitive binding site for beta-endorphin.

N A Shahabi1, K M Linner, B M Sharp.   

Abstract

Naloxone-resistant binding sites for beta-endorphin have previously been observed on transformed peripheral blood mononuclear cells and on the EL4-thymoma cell line. These sites may be related to the naloxone-insensitive immunomodulatory effects of beta-endorphin. The present study was performed 1) to determine whether these sites are present on normal splenocytes and 2) to characterize them. Ficoll-hypaque-purified murine splenocytes were used in a RRA with [125I]beta-endorphin. Neither fresh intact cells obtained from viral antibody-free mice nor membrane preparations showed evidence of binding. However, splenocytes cultured in 5% fetal bovine serum for 24-96 h showed sites on intact cells or membranes (after 3 h in culture no sites were present). Intact cultured splenocytes demonstrated a saturable binding isotherm, and Scatchard analysis showed a single site (Kd = 4.1 X 10(-9) M). Competition studies showed that N-acetyl-beta-endorphin (N-Ac-beta-endorphin)-(1-31) was equipotent to beta-endorphin-(1-31). beta-Endorphin-(6-31) and beta-endorphin-(28-31) were approximately 10- and 1000-fold less potent, respectively, whereas beta-endorphin-(1-27) and naloxone were completely ineffective. Covalent cross-linking of [125I]beta-endorphin to splenocytes and resolution by gel electrophoresis showed bands at 66K and 57K which were displaced equipotently by increasing amounts of beta-endorphin and N-Ac-beta-endorphin. beta-Endorphin-(18-31) or (28-31) were less potent, and naloxone or other opioid ligands selective for receptor subtypes were ineffective. Thus, high affinity, naloxone-insensitive binding sites for beta-endorphin, which show competition characteristics distinctively different from brain opiate receptors, are inducible on normal mouse splenocytes. N-Ac-beta-endorphin, presumed to be an inactivation product of beta-endorphin because it fails to bind brain opiate receptors, may be functional at this naloxone-insensitive binding site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137772     DOI: 10.1210/endo-126-3-1442

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  β-endorphin binding in cultured adrenal cortical cells.

Authors:  R A Gelfand; A Bobrow; L Pham; C Young; L Parker
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

2.  Dual signal transduction through delta opioid receptors in a transfected human T-cell line.

Authors:  B M Sharp; N A Shahabi; W Heagy; K McAllen; M Bell; C Huntoon; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity.

Authors:  Benito Anton; Phillipe Leff; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Lenin Pavón; Martin Martinez; Joseph J Meissler; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  Brain Behav Immun       Date:  2008-04-18       Impact factor: 7.217

4.  Identification of two moieties of beta-endorphin with opposing effects on rat T-cell proliferation.

Authors:  P van den Bergh; J Rozing; L Nagelkerken
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

5.  Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.

Authors:  Saurabh Mehandru; Sherry Deren; Sung-Yeon Kang; Angela Banfield; Aakash Garg; Donald Garmon; Melissa LaMar; Teresa H Evering; Martin Markowitz
Journal:  J Addict Res Ther       Date:  2015

6.  Dopamine D2 Receptor Is Involved in Alleviation of Type II Collagen-Induced Arthritis in Mice.

Authors:  Jian-Hua Lu; Yi-Qian Liu; Qiao-Wen Deng; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Biomed Res Int       Date:  2015-11-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.